It is a food and beverages private limited company based in Rangareddy, Telangana, India, established in 2017.
2017 | Rangareddy, Telangana, India | Struck OffBioclinix Formulations Private Limited, a struck off private limited company, was established on 25 October 2017 in Rangareddy, Telangana, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24303TG2017PTC120251. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Gurram Bharath Chandra (Director), Karthik Bolgam (Director), Sri Krishna Chaitanya Boyapati (Director). It is based at H.No.2-89/1/5/9/A, 2Nd Floor, Gopanpally Village,Gachibowli, Rangareddy, Telangana, 500046.
U24303TG2017PTC120251
120251
25 October 2017
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Bioclinix Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gurram Bharath Chandra | Director | 25 Oct 2017 | Current |
| Karthik Bolgam | Director | 25 Oct 2017 | Current |
| Sri Krishna Chaitanya Boyapati | Director | 25 Oct 2017 | Current |
| Kiran Kumar Kantayapalem | Director | 25 Oct 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Bioclinix Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Bioclinix Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bioclinix Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bioclinix Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioclinix Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gurram Bharath Chandra was appointed as a Director was appointed as a Director on 25 Oct 2017 & has been associated with this company since 8 years 2 months . was documented.
Karthik Bolgam was appointed as a Director was appointed as a Director on 25 Oct 2017 & has been associated with this company since 8 years 2 months . was recorded as a recent event.
Progress on Sri Krishna Chaitanya Boyapati was appointed as a Director was appointed as a Director on 25 Oct 2017 & has been associated with this company since 8 years 2 months . was documented.
The activity Kiran Kumar Kantayapalem was appointed as a Director was appointed as a Director on 25 Oct 2017 & has been associated with this company since 8 years 2 months . was completed.
Progress on Bioclinix Formulations Private Limited was registered on 25 Oct 2017 with Roc Hyderabad & aged 8 years 2 months as per MCA records. was documented.
The CIN of Bioclinix Formulations Private Limited is U24303TG2017PTC120251.
Bioclinix Formulations Private Limited is headquartered at H.No.2-89/1/5/9/A, 2Nd Floor, Gopanpally Village,Gachibowli, Rangareddy, Telangana, 500046.
Bioclinix Formulations Private Limited was incorporated on 25 October 2017.
The current directors of Bioclinix Formulations Private Limited are
The primary industry of Bioclinix Formulations Private Limited is Food And Beverages.
Bioclinix Formulations Private Limited is unlisted.
The authorized capital of Bioclinix Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Bioclinix Formulations Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX